Predictors of skeletal muscle mass in elderly men and women

1999 ◽  
Vol 107 (2) ◽  
pp. 123-136 ◽  
Author(s):  
Richard N. Baumgartner ◽  
Debra L. Waters ◽  
Dympna Gallagher ◽  
John E. Morley ◽  
Philip J. Garry
2005 ◽  
Vol 37 (Supplement) ◽  
pp. S301
Author(s):  
Taishi Midorikawa ◽  
Takashi Abe ◽  
Kiyoshi Sanada ◽  
Charles F. Kearns ◽  
Tetsuo Fukunaga

2008 ◽  
Vol 33 (4) ◽  
pp. 769-774 ◽  
Author(s):  
Jennifer L. Kuk ◽  
Katherine Kilpatrick ◽  
Lance E. Davidson ◽  
Robert Hudson ◽  
Robert Ross

The relationship between skeletal muscle mass, visceral adipose tissue, insulin sensitivity, and glucose tolerance was examined in 214 overweight or obese, but otherwise healthy, men (n = 98) and women (n = 116) who participated in various exercise and (or) weight-loss intervention studies. Subjects had a 75 g oral glucose tolerance test and (or) insulin sensitivity measures by a 3 h hyperinsulinemic–euglycemic clamp technique. Whole-body skeletal muscle mass and visceral adipose tissue were measured using a multi-slice magnetic resonance imaging protocol. Total body skeletal muscle mass was not associated with any measure of glucose metabolism in men or women (p > 0.10). These observations remained independent of age and total adiposity. Conversely, visceral adipose tissue was a significant predictor of various measures of glucose metabolism in both men and women with or without control for age and (or) total body fat (p < 0.05). Although skeletal muscle is a primary site for glucose uptake and deposition, these findings suggest that unlike visceral adipose tissue, whole-body skeletal muscle mass per se is not associated with either glucose tolerance or insulin sensitivity in overweight and obese men and women.


2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 589-589
Author(s):  
Julie Jones ◽  
Sujatha Rajaram ◽  
Celine Heskey ◽  
Rawiwan Sirirat ◽  
Abigail Clarke ◽  
...  

Abstract Objectives We sought to assess the effect of daily consumption of macadamia nuts as 15% of calories on body weight, BMI, waist circumference, percent body fat and skeletal muscle mass in overweight/obese men and women with elevated cardiometabolic risk. Methods Utilizing a randomized crossover design, we randomized 38 subjects to consume macadamia nuts daily as 15% of calories for 8 weeks (intervention) and their usual diet for 8 weeks (control), with a 2-week washout. Three subjects dropped out early; n = 35 for analysis. Subjects were healthy men and postmenopausal women with a BMI of 25–39, a waist circumference of &gt;101.6 cm for men and &gt;88.9 cm for women, and one additional cardiovascular risk factor (fasting plasma glucose &gt;100 mg/dL, triglycerides ≥150 mg/dl, total cholesterol &gt;200 mg/dL, LDL-C &gt; 100 mg/dL, blood pressure ≥130/85 mmHg or taking anti-hypertensive medication). Macadamia nuts were provided in pre-weighed daily portions as 15% of calories calculated using the Mifflin-St. Jeor equation. Percent body fat and skeletal muscle mass (kg) were determined by bioelectrical impedance analysis. A mixed model analysis was performed with treatment, sequence, phase, and baseline values as fixed-effect terms and subjects as a random-effects term. Results Compared to control, consumption of macadamia nuts led to a mean weight change of –348 g (84.13 vs. 83.78 kg; P = 0.15) a mean BMI change of –0.15 kg/m2 (30.61 vs. 30.47 kg/m2; P = 0.12), and a mean waist circumference change of 0.17 cm (107.41 vs. 107.58 cm; P = 0.61). Percent body fat increased by an average of 0.26% after eating nuts (42.70 vs. 42.96%; P = 0.16). Skeletal muscle mass was slightly but significantly lower after eating nuts with a mean change of –0.237 kg (26.33 vs. 26.09 kg; P = 0.017). Conclusions Daily consumption of high-fat macadamia nuts for eight weeks in overweight and obese individuals did not change anthropometrics including body weight, BMI, waist circumference, and % body fat. Skeletal muscle mass was slightly lowered but likely not clinically relevant. Funding Sources Hort Innovation, Sydney, Australia.


2010 ◽  
Vol 58 (11) ◽  
pp. 2069-2075 ◽  
Author(s):  
Lex B. Verdijk ◽  
Tim Snijders ◽  
Milou Beelen ◽  
Hans H.C.M. Savelberg ◽  
Kenneth Meijer ◽  
...  

Aging ◽  
2020 ◽  
Vol 12 (21) ◽  
pp. 21023-21036
Author(s):  
Nicholas T. Kruse ◽  
Petra Buzkova ◽  
Joshua I. Barzilay ◽  
Rodrigo J. Valderrabano ◽  
John A. Robbins ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Chuan-Wei Yang ◽  
Chia-Ing Li ◽  
Tsai-Chung Li ◽  
Chiu-Shong Liu ◽  
Chih-Hsueh Lin ◽  
...  

Abstract This study aimed to explore the combined effects of having sleep problems and taking sleeping pills on the skeletal muscle mass and performance of community-dwelling elders. A total of 826 participants who have complete information regarding dual-energy X-ray absorptiometry examination, questionnaire, and physical performance tests were included. The status of having sleep problems and taking sleeping pills was assessed with a self-reported questionnaire. The prevalence rates of sleep problems among older men and women were 37.4% and 54.5%, respectively. After multivariate adjustment, the mean height-adjusted skeletal muscle indices for elders having sleep problems and taking sleeping pills among men and women were 7.29 and 5.66 kg/m2, respectively, which were lower than those without sleep problems (P = 0.0021 and P = 0.0175). The performance of the older men having sleep problems and taking sleeping pills in terms of walking speed, grip strength, and number of squats, was poorer than those of the older men without sleep problems. The status of having sleep problems and taking sleeping pills was correlated with low skeletal muscle mass and poor physical performance in community-dwelling elders. These findings suggest that having sleep problems and taking sleeping pills are associated with having sarcopenia among community elderly.


Sign in / Sign up

Export Citation Format

Share Document